Puzzling encounter of idiopathic pasteurella bacteraemia

is a gram-negative coccobacillus that is commonly transmitted through animal bites including cats and dogs. The degree of infection can be worrisome in the immunosuppressed population with a stark correlation in patients with cirrhosis. However, taking that population into account, only 13 cases of bacteraemia have been recorded with the majority of those cases having cirrhotic liver disease along with multiple comorbidities. Here, we present an elderly patient with only pertinent medical history of mixed hyperlipidaemia who presents after a mechanical fall with acute renal failure and septic shock secondary to bacteraemia

Seroprevalence and genotyping of hepatitis B, hepatitis C and HIV among healthy population and Turkish soldiers in Northern Cyprus

AIM: To compare the prevalence of hepatitis viral markers among soldiers from Turkey, blood donors from Northern Cyprus, and soldiers from Northern Cyprus. METHODS: Hepatitis B surface antigen (HBsAg), anti-HCV and anti-human immunodeficiency virus (HIV) seroprevalence, HBV DNA, HCV RNA and HCV genotyping among soldiers from Turkey (group I), civil blood donors from Northern Cyprus (group R), and soldier candidates from Northern Cyprus (group M) were studied and compared to one another. In total, 17545 cases (13546 males and 3999 females with a mean age of 34.5 +/- 10.3 year, group I = 11234, group II = 5057, and group III = 1254) were included into the study. RESULTS: Among all cases, HBsAg positivity rates were 2.46%, anti-HCV was 0.46% and anti-HIV was 0.00%. HBV DNA was 2.25%, HCV RNA was 0.33% in all groups. Hl3sAg positivity rates were 2.16% in group I, 3.00% in group II and 2.71% in group M. There was a significant difference between group I and group II (chi(2) = 6.11, P = 0.047 < 0.05). Anti-HCV positivity rates were 0.45% in group I, 0.45% in group II, and 0.56% in group M. Genotypes of HCV were 1b and 1a in group I, 1b, la and 2 in group II, and 1b, 1a in group III. HBsAg carrier rates were 2.20% in females and 2.53% in males. Anti-HCV prevalence was 0.38% in females and 0.48% in males. Hl3sAg positivity rates were 2.53% in individuals younger than 50, and 1.47% in older than 50. There was a significant difference between the two groups (chi(2) = 23.48, P = 0.001). CONCLUSION: Prevalences of Hl3sAg, HCV and HIV infections in Northern Cyprus population are similar to those of Turkey. (C) 2006 The WJG Press. All rights reserved

Pneumothorax bei COVID-19-Erkrankung – Inzidenz und klinische Merkmale

Background: Spontaneous pneumothorax is a rarely occurring complication of viral pneumonia in COVID-19. The exact incidence and risk factors are still unclear. In the present work we examine the incidence and outcomes of more than 3,000 patients with pneumothorax who were admitted to our clinic with suspected COVID-19 pneumonia. METHODS: We retrospectively reviewed the cases of COVID-19 patients admitted to our clinic. To calculate the incidence of this event, patients diagnosed with spontaneous pneumothorax were identified and their clinical features were extensively documented. Clinical outcome data were collected. The individual cases are each presented in the form of a short summary. Results: Between March 1st and March 8th June 2020, 3368 patients with suspected COVID-19 pneumonia were admitted to our clinic; of these, 902 patients had a positive nasopharyngeal smear. Six COVID-19 patients who developed spontaneous pneumothorax were identified (0.66%). Baseline imaging showed diffuse bilateral frosted glass opacities and consolidations in these patients, predominantly in the posterior and peripheral lung regions. Four of the six patients were mechanically ventilated. Chest drainage was required in all patients. In all cases there was no direct relationship between the pneumothorax and mortality (66.6%). Conclusion: Spontaneous pneumothorax is a rare complication of viral pneumonia in COVID-19 that can occur without mechanical ventilation.Lewis Katz School of MedicineThoracic Medicine and Surger

Pneumothorax in COVID-19 disease- incidence and clinical characteristics

Abstract Background Spontaneous pneumothorax is an uncommon complication of COVID-19 viral pneumonia. The exact incidence and risk factors are still unknown. Herein we review the incidence and outcomes of pneumothorax in over 3000 patients admitted to our institution for suspected COVID-19 pneumonia. Methods We performed a retrospective review of COVID-19 cases admitted to our hospital. Patients who were diagnosed with a spontaneous pneumothorax were identified to calculate the incidence of this event. Their clinical characteristics were thoroughly documented. Data regarding their clinical outcomes were gathered. Each case was presented as a brief synopsis. Results Three thousand three hundred sixty-eight patients were admitted to our institution between March 1st, 2020 and June 8th, 2020 for suspected COVID 19 pneumonia, 902 patients were nasopharyngeal swab positive. Six cases of COVID-19 patients who developed spontaneous pneumothorax were identified (0.66%). Their baseline imaging showed diffuse bilateral ground-glass opacities and consolidations, mostly in the posterior and peripheral lung regions. 4/6 cases were associated with mechanical ventilation. All patients required placement of a chest tube. In all cases, mortality (66.6%) was not directly related to the pneumothorax. Conclusion Spontaneous pneumothorax is a rare complication of COVID-19 viral pneumonia and may occur in the absence of mechanical ventilation. Clinicians should be vigilant about the diagnosis and treatment of this complication. </jats:sec

Pneumothorax bei COVID-19-Erkrankung – Inzidenz und klinische Merkmale

Hintergrund: Der Spontanpneumothorax ist eine selten auftretende Komplikation der Viruspneumonie bei COVID-19. Die genaue Inzidenz sowie die Risikofaktoren sind weiter unklar. In der vorliegenden Arbeit untersuchen wir die Inzidenz und die Outcomes von mehr als 3.000 Patienten mit Pneumothorax, die mit Verdacht auf COVID-19-Pneumonie in unsere Klinik aufgenommen wurden. Methoden: Wir überprüften retrospektiv die Fälle von COVID-19-Patienten, die in unsere Klinik aufgenommen worden waren. Zur Berechnung der Inzidenz dieses Ereignisses wurden Patienten mit diagnostiziertem Spontanpneumothorax identifiziert und ihre klinischen Merkmale wurden umfassend dokumentiert. Es wurden Daten zum klinischen Outcome erhoben. Die einzelnen Fälle werden jeweils in Form einer kurzen Zusammenfassung vorgestellt. Ergebnisse: Zwischen 1. März und 8. Juni 2020 wurden 3368 Patienten mit Verdacht auf eine COVID-19-Pneumonie in unsere Klinik aufgenommen; von diesen wiesen 902 Patienten einen positiven Nasopharyngealabstrich auf. Es wurden sechs COVID-19-Patienten, die einen Spontanpneumothorax entwickelten, identifiziert (0,66 %). Die Baseline-Bildgebung zeigte bei diesen Patienten diffuse bilaterale Milchglastrübungen und Konsolidierungen, überwiegend in den posterioren und peripheren Lungenregionen. Vier der sechs Patienten wurden mechanisch beatmet. Bei allen Patienten war eine Thoraxdrainage erforderlich. In allen Fällen bestand kein direkter Zusammenhang zwischen dem Pneumothorax und der Mortalität (66,6%). Schlussfolgerung: Der Spontanpneumothorax ist eine seltene Komplikation der Viruspneumonie bei COVID-19, die auch ohne mechanische Beatmung auftreten kann. Kliniker sollten im Hinblick auf die Diagnose und Behandlung dieser Komplikation wachsam sein. </jats:p